Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Filed Chapter 11
Inv. presentation
Quarterly results
Appointed director
CC transcript
HELICOS BIOSCIENCES CORP (HLCS) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/10/2012 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter to Securities and Exchange Commission from PricewaterhouseCoopers LLP"
11/15/2012 8-K Quarterly results
09/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/31/2012 8-K Other Events
08/29/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Letter Agreement re: Risk Premium Agreement, by and among the Company and each of the Lenders identified therein"
08/06/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "License Agreement"
04/10/2012 8-K Form 8-K - Current report
03/09/2012 8-K Other Events
01/10/2012 8-K Form 8-K - Current report
12/01/2011 8-K Form 8-K - Current report
09/22/2011 8-K Form 8-K - Current report
09/13/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/30/2011 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Helicos BioSciences Expands Its License with Arizona Technology Enterprises Covering Next Generation Sequencing; New Patents Continue to Issue CAMBRIDGE, Mass., August 30, 2011 — Helicos BioSciences Corporation announced today that it has amended its existing license with Arizona Technology Enterprises to include all activities that fall within the scope of, or constitute the practice of, the licensed patents, and gives Helicos full and unencumbered rights to the associated intellectual property. The license, which gives Helicos rights to several patents covering sequencing-by-synthesis methods, now expressly includes detection methods that do not rely on optically-labeled nucleotides. “The expanded license is another example of Helicos's successful strategy of systematically expanding its..."
06/30/2011 8-K Form 8-K - Current report
04/29/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/01/2011 8-K Form 8-K - Current report
11/18/2010 8-K Form 8-K - Current report
11/15/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
10/15/2010 8-K Form 8-K - Current report
09/21/2010 8-K Form 8-K - Current report
06/25/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Helicos BioSciences Announces Launch of Diagnostics Business"
06/22/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/14/2010 8-K Form 8-K - Current report
05/17/2010 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Helicos BioSciences Announces Strategic Focus on Diagnostics Markets and Operational Restructuring"
04/15/2010 8-K Form 8-K - Current report
02/12/2010 8-K Form 8-K - Current report
12/17/2009 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Underwriting Agreement between the Company and Thomas Weisel Partners LLC",
"Form of Warrant",
"Opinion of Goodwin Procter LLP",
"Helicos BioSciences Corporation Announces $6.4 Million Registered Direct Offering"
12/03/2009 8-K Investor presentation
Docs: "Helicos BioSciences Presents an Overview of Single Molecule Sequencing Technology in Clinical Diagnostics",
"Helicos BioSciences Corporation Presentation Transcript",
"Helicos BioSciences Corporation Presentation Materials"
11/10/2009 8-K Form 8-K - Current report
10/27/2009 8-K Form 8-K - Current report
10/13/2009 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Fifth Amendment to Lease"
09/28/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "First Amendment to Change in Control Agreement, by and between Ronald A. Lowy and Helicos BioSciences Corporation"
09/17/2009 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Warrant",
"Securities Purchase Agreement, between Helicos and each of the Purchasers identified therein",
"Registration Rights Agreement, between Helicos and each of the Holders identified there",
"Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement CAMBRIDGE, Mass., Sep 16, 2009 — Helicos BioSciences Corporation , a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures and Ron Lowy, the Company's chief executive officer, to raise approximately $10 million in gross proceeds in a private placement through the sale of shares of its common stock and warrants. The Company estimates that net proceeds from the offering will be approximately $9.4 million, after deducting placement ..."
09/11/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy